Related Experiment Video
Updated: Jun 21, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Manipulation of T(H)17 responses in pulmonary immunity and disease through vaccination
Gregory F Sonnenberg1, David B Weiner
1Department of Pathobiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Since the discovery of a novel subset of CD4(+) T helper cells, T(H)17 cells have been implicated in a wide range of human diseases, including autoimmunity, allergic reactions and autoinflammatory diseases. Conversely, it has also been determined that T(H)17 cells are required to mount a protective immune response to a number of pathogens. It has therefore been of great interest to manipulate T(H)17 responses to either prevent disease or promote immunity. Vaccination is a particularly attractive approach for this manipulation. With a focus on the pulmonary mucosal environment, we herein review T(H)17 responses and potential methods for manipulation.
Since the discovery of a novel subset of CD4(+) T helper cells, T(H)17 cells have been implicated in a wide range of human diseases, including autoimmunity, allergic reactions and autoinflammatory diseases. Conversely, it has also been determined that T(H)17 cells are required to mount a protective immune response to a number of pathogens. It has therefore been of great interest to manipulate T(H)17 responses to either prevent disease or promote immunity. Vaccination is a particularly attractive approach for this manipulation. With a focus on the pulmonary mucosal environment, we herein review T(H)17 responses and potential methods for manipulation.
Related Concept Videos
Vaccinations
Vaccines
Microorganisms in Medicine and Therapeutics
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Tumor Immunotherapy
Cell-mediated Immune Responses

